Form 4: TerrAscend Corp. Director Modifies Stock Options

TerrAscend Corp. director Craig A. Collard's stock options were modified to a lower exercise price following the satisfaction of a service requirement.

Summary

• This filing reports a modification to stock options held by TerrAscend Corp. director Craig A. Collard.
• The modification, approved by shareholders at the annual general meeting on June 24, 2025, adjusted the exercise price of previously granted options.
• The new exercise price is $0.26 per common share, representing the market price calculated as the volume-weighted average trading price for the five trading days prior to the amendment date.
• This modification was conditional on Collard's continued employment for at least 12 months from June 24, 2025, which was met on June 24, 2026.
• All other terms of the options, including expiration and vesting, remain unchanged.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a routine administrative change to an executive's stock options following the satisfaction of pre-defined conditions.

Positives

• The modification of stock options to a lower exercise price ($0.26) can be seen as a positive incentive for the director, aligning their interests with the company.
• The satisfaction of the service requirement indicates continued commitment from the director.
• The modification was approved by shareholders, indicating corporate governance alignment.

Negatives

• The original exercise price of the options is not explicitly stated, making it difficult to quantify the exact benefit of the price reduction.
• The filing does not provide the current market price of the stock, only the basis for the new exercise price.

Risks

• The value of the modified options is directly tied to the future performance of TerrAscend Corp.'s stock price.
• If the stock price does not appreciate significantly, the modified options may not provide substantial financial benefit.

Future Outlook

The future outlook for the modified options depends on the future trading price of TerrAscend Corp. common shares. All other terms, including expiration dates, remain unmodified.

Management Comments

• Shareholders approved the modification of previously-granted options held by employees including the Reporting Person such that, conditional on the Reporting Person's continued employment with the Company for a period of at least 12 months from June 24, 2025, the original exercise price of such options would be modified to $0.26 per common share.
• On June 24, 2026, the Amendment Service Requirement was satisfied and the original exercise price of the options was automatically modified to the Market Price.
• All other terms and conditions of the option, including the expiration date, remain unmodified, including the vesting terms.

Industry Context

StockSavvy.ai notes that option repricing or modification is a common practice in the cannabis industry, particularly for companies seeking to retain key talent during periods of market volatility or to align executive compensation with current market conditions.

Corporate Governance

Stakeholder Impact

• Shareholders: The modification of options to a lower exercise price could potentially dilute shareholder value if the stock price does not increase sufficiently to make these options valuable. However, it also serves as a retention tool for key management.
• Employees: The modification benefits the reporting person (Director Craig A. Collard) by reducing the cost to acquire company stock, potentially increasing their incentive to drive company performance.
• Management: The change reinforces the alignment of management's financial interests with the company's stock performance.

Next Steps

• The modified options will remain subject to their original expiration and vesting terms.
• Continued employment of Craig A. Collard with TerrAscend Corp. for the duration of the option terms.

Key Dates

Keywords

TerrAscend Corp., TSNDF, Form 4, Stock Options, Director, Beneficial Ownership, Securities Exchange Act, Exercise Price, AGM, Shareholder Approval